10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Tri-City Cardiology’s Ambulatory Surgical Center Surpasses 6,000 Procedures, Marking a Major Milestone in Outpatient Cardiovascular Care
LG NOVA UNVEILS NEXT GENERATION OF AI-FIRST VENTURES AT CES 2026
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
2026 Calls for a Global Health System Connectivity Compact: EHR/EMR, Interoperability, and Cybersecurity Vendors Urged to Protect Continuity of Care During Conflict and Recovery
Partnership includes use of PathAI’s CE-IVDR-marked AISight® Dx1 digital pathology image management system at a group of Austrian pathology laboratoriesBOSTON...
Oversubscribed £50m Series B led by SV Health Investors’ Dementia Discovery Fund, alongside other new investors British Business Bank, M...
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) The...
Vancouver, British Columbia--(Newsfile Corp. - September 8, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or...
Burlington, Ontario--(Newsfile Corp. - September 8, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the...
Excellence Kelyniam Global, Inc. Uplists to OTCID Market Tier CANTON, Conn., Sept. 8, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (OTC:...
Is the DEA the Epitome of Ineptitude?"Why is the VA importing cannabis that U.S. companies have been ready to produce...
Hemogenyx Pharmaceuticals Announces Manufacturing Partnership with Made Scientific to Advance HG-CT-1 CAR-T Therapy CITY OF LONDON, GB / ACCESS Newswire...
Study reveals how Cytovale's IntelliSep® sepsis test enables early sepsis risk stratification and more precise documentation, increasing SEP-1 compliance by...
SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading...
Chemotherapy-free combination regimen has the potential to usher in new era for first-line treatment, with median overall survival projected to...
- 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and 24-hour urine calcium in the normal reference range within 5...
No-cost access available to qualified researchers via open-source federated data platformSAN FRANCISCO, Sept. 06, 2025 (GLOBE NEWSWIRE) -- 23andMe Research...
Medicaid payment suspensions disrupt operations for Housing Stabilization providers and vulnerable clients in Minnesota. MINNEAPOLIS, MN / ACCESS Newswire /...
DELRAY BEACH, Fla., Sept. 6, 2025 /PRNewswire/ -- The global Digital Health Market, valued at US$162.1 billion in 2024, stood...
DELRAY BEACH, Fla., Sept. 6, 2025 /PRNewswire/ -- The global sensor patch market is projected to grow from USD 6.32...
Black Book Research pre-event survey reveals attendee priorities: smart hospitals, population health, and compliance-ready solutions DUBAI, UAE / ACCESS Newswire...
After decades of outreach and evidence—never refuted—it is urgent to fund two 3D-CBS devices that could halve cancer deaths, and...
New data demonstrate amivantamab combination significantly reduces common EGFR and MET resistance mutations seen with EGFR TKIs1 BEERSE, BELGIUM ,...
TORONTO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a...
